UNIV MISSOURI RESEARCH REACTOR CENTER

Overview

UNIV MISSOURI RESEARCH REACTOR CENTER is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering LUTETIUM (LU-177) CHLORIDE RADIOPHARMACEUTICAL PRECURSOR; NCA LUTETIUM LU-177 CHLORIDE SOLUTION; SODIUM IODIDE I-131 SOLUTION.

API / Drug Master Files

UNIV MISSOURI RESEARCH REACTOR CENTER holds 3 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• NCA LUTETIUM LU-177 CHLORIDE SOLUTIONActive2023-05-31
• SODIUM IODIDE I-131 SOLUTIONActive2018-08-10
• LUTETIUM (LU-177) CHLORIDE RADIOPHARMACEUTICAL PRECURSORActive2016-01-08
• CONCENTRATED POTASSIUM MOLYBDATE (CMO-99) FINAL INTERMEDIATE RADIOCHEMICALInactive2020-09-22
• POTASSIUM MOLYBDATE (MO-99) FINAL INTERMEDIATE RADIOCHEMICALInactive2012-09-11

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to UNIV MISSOURI RESEARCH REACTOR CENTER in our records. PharmaTek screens the full directory against live FDA enforcement data.